Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, signaling a newer version of the page template or backend update. This change does not modify study content, eligibility criteria, or results.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.6.2 was added to replace the previous v3.6.0 in the page footer, signaling a new version of the page. This likely reflects minor updates to content or formatting rather than substantive changes to the study information.SummaryDifference0.0%

- Check34 days agoChange DetectedThe study record now displays 'No longer looking for participants', indicating recruitment has closed. New navigational/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check41 days agoChange DetectedPage revision label updated from v3.5.4 to v3.5.5, reflecting a newer build version. This metadata-level change does not alter the study details, eligibility criteria, or results information presented on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a newer version of the page. This update reflects a backend or content refresh without altering the displayed study details.SummaryDifference0.0%

- Check77 days agoChange DetectedPage revision tag updated from v3.5.2 to v3.5.3, indicating a newer version of the page. This is a metadata/versioning change and does not alter the study content presented on the page.SummaryDifference0.0%

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.